Primer: Jaguar Health (JAGX US) - Aug 2026
Jaguar Health is a commercial-stage pharmaceutical company focused on developing and commercializing plant-based, non-opioid prescription...
96 Views
Jaguar Health (JAGX US): Synthetic Expert Call Transcript (26 Jul 2026)
Future Pak Deal Milestones are Not Low-Hanging Fruit: While the U.S. licensing agreement with Future Pak provided $19.0 million in upfront...
115 Views
IPO Databook: Jaguar Health (JAGX US) - Jul 2026
Jaguar Health develops novel plant-derived prescription drugs for human GI diseases and non-prescription GI products for animals. This prospectus...
109 Views
Biopharma Week in Review - Jul 29, 2024
Last week, IONS matched Ultragenyx’s Angelman benefit, with maybe better safety. PFE and SGMO had approvable gene therapy results in hemophilia A,...
340 Views
No more insights